CKD animals treated with the NOX1/4 inhibitor GKT and the calcimimetic drug KP demonstrated decreased calcification, 8‐OHdG, and NOX4 expression in the vasculature, decreased PTH, and increased cFGF23. The gene discussed is PTH; the disease is chronic kidney disease.